The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals ...

The Neffy nasal spray treats adults and children and could help the more than 1 in 3 U.S. adults reported to have a seasonal or food allergy.

Health FDA approves first nasal spray to treat dangerous allergic reactions “There’s a real unmet medical need for a large portion of the population.” ...

The nation in brief. FDA approves first allergy nasal spray. August 10, 2024 at 2:53 a.m. by Compiled by Democrat-Gazette Staff From Wire Reports ...

On Friday, the FDA announced the approval of neffy, an epinephrine nasal spray by ARS Pharmaceuticals, for emergency treatment of allergic reactions in adults and pediatric patients who weigh more ...

The FDA has approved the first nasal spray for severe allergic reactions. Called Neffy, the move expands options beyond needle-based treatments like the EpiPen.

FDA approves epinephrine nasal spray, a needle-free alternative to EpiPen by Nathaniel Weixel - 08/09/24 1:45 PM ET by Nathaniel Weixel - 08/09/24 1:45 PM ET ...

The FDA has approved the first nasal spray treatment for severe allergic reactions, increasing access to potentially life-saving treatment.

FDA Approves First Nasal Spray To Treat Allergic Reactions; ... If you begin to feel an exercise-induced allergy, make sure to immediately stop what you are doing and take a rest.

FDA approves first nasal spray for severe allergic reactions ... Allergy and Critical Care at the FDA’s Center for Drug Evaluation and Research. “As a result, ...

By JONEL ALECCIA U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration ...